logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
E

Expert Review of Pharmacoeconomics & Outcomes Research

IF1.5
Papers58
Citations
Journal Papers 58
Publication Date
delete
Knowledge, perception and application of pharmacoeconomics among healthcare professionals in Malaysia
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-04-01
delete0
PREAI
deleteChandriah, Haarathi; Low, Ee Vien; Ahmad, Nur Sufiza; Ahmat, Azmi Nor Mohd Farez; Farok, Izzati Mohd; Wong, Jacqueline Hui Yi; Fun, Weng Hong; Thanimalai, Subramaniam; Ng, Chin Hui; Ibrahim, Nor Haizan; Rosli, Mohd Rozaini; Lim, Kenneth Lik Chien; Choo, Yai Wen
deleteShare
deleteSave
Burden Tree - a conceptual framework for the burden associated with pediatric infectious diseases: a Delphi approach
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-04-01
delete0
PREAI
deleteCarias, Cristina; Riley, Danielle; Eiden, Amanda L.; Enstone, Ashley L.; Whittle, Isabelle J.; Marshall, Deanna B.; Oswald, Charlotte W.; Tilford, J. Mick
deleteShare
deleteSave
Cost-effectiveness analysis of tucatinib plus trastuzumab versus pertuzumab plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteLiu, Mengmeng; Zhong, Lu; Dong, Mei; Liu, Tong
deleteShare
deleteSave
Net benefits of investing in pulse oximetry and oxygen for childhood pneumonia in high burden countries
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteColbourn, Tim; King, Carina
deleteShare
deleteSave
Comparative cost per responder analysis of ciltacabtagene autoleucel and real-world standard of care therapy in patients with lenalidomide-refractory multiple myeloma
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteHansen, Doris K.; Lu, Xiaoxiao; Castaneda Puglianini, Omar; Zhang, Eileen; Usmani, Saad Z.; Sachdev, Rameet; Perciavalle, Matthew; De Wiest, Denise; Huo, Stephen; Lee, Seina; Qureshi, Zaina P.; Jagannath, Sundar
deleteShare
deleteSave
Impact of early-stage immunotherapy on health and work productivity in the Czech Republic, 2024-2033
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteBlezer, Gittan; Patterson, Karl; Micoch, Tomas; Alahakoon, Jana; Lai, Yizhen; Khurana, Vivek; Aguiar-Ibanez, Raquel
deleteShare
deleteSave
Duration changes and decision-making in DCETTO: evidence from SF-6Dv2
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteAmeri, Hosein; Poder, Thomas G.
deleteShare
deleteSave
Climate-related risk and pharmaceutical market dynamics in India and USA: evidence from transfer entropy, BEKK GARCH, and coherence wavelet
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteHarikumar, Yedhu; Muralikrishna, Muthumeenakshi; Muralikrishna, Prakasam; Alola, Andrew Adewale
deleteShare
deleteSave
Prevention, artificial intelligence, and mathematics in health economics: a framework for dynamic value modeling under long-term uncertainty
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteMaas, Lieke; Yaylali, Ayshe; Hiligsmann, Mickael
deleteShare
deleteSave
Medication adherence research: expert perspectives on key HEOR trends for 2026
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteAgh, Tamas; Borah, Bijan; Vervloet, Marcia; Hiligsmann, Mickael
deleteShare
deleteSave
Cost-effectiveness analysis of point-of-care A1C tests in the primary care setting of Iran
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteMousavi, Abdoreza; Raadabadi, Mehdi; Darvishi, Ali
deleteShare
deleteSave
Trends in antidepressant utilization, expenditure, and demographic prescribing patterns in Jordan: a retrospective analysis
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteAl Twahya, Safa' F.; Hijazeen, Rima; Almomani, Hamzeh; Alefan, Qais; Alabbadi, Ibrahim
deleteShare
deleteSave
Physicians' preferences for direct-acting antivirals in the treatment of chronic hepatitis C: evidence from a discrete choice experiment in China
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteLi, Yan; Du, Junni; Tian, Chenhui; Ma, Aixia; Tao, Tiantian; Chen, Pingyu
deleteShare
deleteSave
Standardized pharmaceutical service improves medication adherence and reduces anxiety and depression in patients with chronic obstructive pulmonary disease (nov, 10.1080/14737167.2025.2586651, 2025)
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteLin, M.; Chen, Y.; Zou, Q.; Wang, Z.; Chen, Z.; Liu, Y.
deleteShare
deleteSave
Developing, updating and validating DepMod 2.0: an R-based decision-analytic model for the cost-effectiveness of depression interventions
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deletePeeters, Stijn B.; Thielen, Frederick W.; Wijnen, Ben F. M.
deleteShare
deleteSave
Impact of an expanded male catch-up HPV vaccination program on the clinical and economic burden of HPV-associated diseases in Denmark: a modeling study
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-02-01
delete0
PREAI
deleteTheisen Honore, Emilie; Le Fevre, Thomas; Pavelyev, Andrew; Sabale, Ugne; Gronhoj, Christian; Daniels, Vincent
deleteShare
deleteSave
Economic evaluation of percutaneous patent foramen ovale closure versus medical therapy in patients with a cryptogenic stroke: a systematic review
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-02-01
delete0
PREAI
deleteRezapour, Aziz; Rezaeian, Mohsen; Bagheri Faradonbeh, Saeed; Barzegar, Mohammad; Zareh Askari, Ali; Pourasghari, Hamid; Peighambari, Mohammad Mehdi; Souresrafil, Aghdas
deleteShare
deleteSave
Comparative cost-utility analysis of ixekizumab, tofacitinib, and golimumab in psoriatic arthritis: a real-world Markov model simulation
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-02-01
delete0
PREAI
deleteQueiro, Ruben; Brana, Ignacio; Alvarez, Paula; Loredo, Marta; Pardo, Estefania; Burger, Stefanie
deleteShare
deleteSave
Concerns on methodological assumptions in the health economic evaluation of return-to-work interventions
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-02-01
delete0
PREAI
deleteGandjour, Afschin
deleteShare
deleteSave
Health technology assessment reports for oncology medications in Canada from 2018 to 2025: methodological critiques on manufacturers' submissions and a comparison between manufacturers and Canada's Drug Agency (CDA) analyses
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-02-01
delete0
PREAI
deleteMardani Jadid, Sepideh; Dokhaei, Mobina; Dini, Naeemeh; Tajadod, Masoud; Azizi Khezri, Dorsa; Hariri, Kimia; Levine, Mitchell; Mirzayeh Fashami, Fatemeh
deleteShare
deleteSave